You just read:

Goodwin Biotechnology Announces the Completion of cGMP Manufacturing of an IgM Monoclonal Antibody and IgM : Ligand Conjugate for Q Therapeutics, and Successful Clearance of Q Therapeutics' IND Submission for Q-Cells® Cell Therapy in ALS

News provided by

Goodwin Biotechnology, Inc.

Jul 13, 2015, 09:00 ET